Company Badge
USPTO Data Jan 1 1976 - Oct 6 2026
10 Patents
#53 in Oslo
#167 in Norway
#55,986 in the World
Gemvax as
Forward Citations = 206
13 inventors:
Gemvax as
% Expired Patents = 60.0
CIPO Patents = 2
EPO Patents = 7
Forward Citations = 206
Loading Chart...
Loading Chart...
13 inventors (with patents filed for the assignee):
Jon Amund Eriksen (10 out of 17 patents)
Gustav Gaudernack (9 out of 21 patents)
Mona Møller (7 out of 7 patents)
4. Marianne Klemp Gjertsen (6 out of 6 patents)
5. Ingvil Sæterdal (3 out of 3 patents)
6. Mona Moller (2 out of 2 patents)
7. Ingvil Saeterdal (2 out of 2 patents)
8. Stein Sæbøe-Larssen (2 out of 2 patents)
9. Stein Sæbøe-Larsen (2 out of 2 patents)
10. Stein Sæøe-Larssen (1 out of 1 patent)
11. Gustay Gaudernack (1 out of 1 patent)
12. Mona Møller (1 out of 1 patent)
13. Ingvil Sæterdal (1 out of 1 patent)
14. Stein Saeboe-Larssen (0 patent)
15. Mona Moeller (0 patent)
10 patents:
Gemvax is a biopharmaceutical company dedicated to the development of innovative cancer therapies. With a focus on personalized medicine, Gemvax utilizes cutting-edge technologies to create targeted treatments that aim to improve patient outcomes. Through strategic partnerships and collaborations, Gemvax continues to advance the field of oncology and bring novel therapies to market.
Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
2 patents (CIPO):
Please report any incorrect information to [email protected]
7 patents (EPO):
Please report any incorrect information to [email protected]